Your browser doesn't support javascript.
loading
ctDNA monitoring using patient-specific sequencing and integration of variant reads.
Wan, Jonathan C M; Heider, Katrin; Gale, Davina; Murphy, Suzanne; Fisher, Eyal; Mouliere, Florent; Ruiz-Valdepenas, Andrea; Santonja, Angela; Morris, James; Chandrananda, Dineika; Marshall, Andrea; Gill, Andrew B; Chan, Pui Ying; Barker, Emily; Young, Gemma; Cooper, Wendy N; Hudecova, Irena; Marass, Francesco; Mair, Richard; Brindle, Kevin M; Stewart, Grant D; Abraham, Jean E; Caldas, Carlos; Rassl, Doris M; Rintoul, Robert C; Alifrangis, Constantine; Middleton, Mark R; Gallagher, Ferdia A; Parkinson, Christine; Durrani, Amer; McDermott, Ultan; Smith, Christopher G; Massie, Charles; Corrie, Pippa G; Rosenfeld, Nitzan.
Afiliação
  • Wan JCM; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Heider K; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Gale D; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Murphy S; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Fisher E; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Mouliere F; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Ruiz-Valdepenas A; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Santonja A; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Morris J; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Chandrananda D; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Marshall A; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Gill AB; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Chan PY; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Barker E; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.
  • Young G; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Cooper WN; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Hudecova I; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Marass F; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Mair R; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Brindle KM; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Stewart GD; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Abraham JE; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Caldas C; Warwick Clinical Trials Unit, University of Warwick, Coventry CV4 7AL, UK.
  • Rassl DM; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Rintoul RC; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Alifrangis C; Department of Radiology, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Middleton MR; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Gallagher FA; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Parkinson C; Cambridge Clinical Trials Unit-Cancer Theme, Cambridge CB2 0QQ, UK.
  • Durrani A; Cambridge Clinical Trials Unit-Cancer Theme, Cambridge CB2 0QQ, UK.
  • McDermott U; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Smith CG; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Massie C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Corrie PG; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
  • Rosenfeld N; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
Sci Transl Med ; 12(548)2020 06 17.
Article em En | MEDLINE | ID: mdl-32554709

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA de Neoplasias / DNA Tumoral Circulante Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA de Neoplasias / DNA Tumoral Circulante Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article